NASDAQ:PRPO Precipio (PRPO) Stock Price, News & Analysis $6.03 -0.70 (-10.40%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$6.14 +0.11 (+1.82%) As of 04/25/2025 06:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Precipio Stock (NASDAQ:PRPO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Precipio alerts:Sign Up Key Stats Today's Range$5.51▼$6.9050-Day Range$4.50▼$10.1452-Week Range$3.90▼$10.74Volume9,175 shsAverage Volume9,050 shsMarket Capitalization$9.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPrecipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.Read More… Precipio Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks20th Percentile Overall ScorePRPO MarketRank™: Precipio scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Precipio. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Precipio is -3.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Precipio is -3.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPrecipio has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Precipio's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.58% of the float of Precipio has been sold short.Short Interest Ratio / Days to CoverPrecipio has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Precipio has recently increased by 96.12%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPrecipio does not currently pay a dividend.Dividend GrowthPrecipio does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.58% of the float of Precipio has been sold short.Short Interest Ratio / Days to CoverPrecipio has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Precipio has recently increased by 96.12%, indicating that investor sentiment is decreasing significantly. News and Social Media2.1 / 5News Sentiment0.72 News SentimentPrecipio has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Precipio this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for PRPO on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Precipio insiders have bought more of their company's stock than they have sold. Specifically, they have bought $474.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders13.30% of the stock of Precipio is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.45% of the stock of Precipio is held by institutions.Read more about Precipio's insider trading history. Receive PRPO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter. Email Address PRPO Stock News HeadlinesPrecipio trading halted, volatility trading pauseApril 24 at 11:59 PM | markets.businessinsider.comEarnings call transcript: Precipio Q4 2024 sees revenue growth, strategic shiftsApril 2, 2025 | investing.comHere’s How to Claim Your Stake in Elon’s Private Company, xAIElon Musk has done it again. He’s developed a powerful new AI model that’s already turning heads — and turning the industry upside down. Some say it could threaten Google’s search engine dominance. Others believe it could mark the beginning of the end for ChatGPT.April 26, 2025 | Brownstone Research (Ad)Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth ...April 2, 2025 | finance.yahoo.comPrecipio, Inc. (NASDAQ:PRPO) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comPrecipio Reports Positive Q4 Financial ResultsApril 1, 2025 | tipranks.comPrecipio, Inc. (PRPO) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comPrecipio Announces Q4 and year-end 2024 Shareholder Update CallMarch 17, 2025 | globenewswire.comSee More Headlines PRPO Stock Analysis - Frequently Asked Questions How have PRPO shares performed this year? Precipio's stock was trading at $5.54 on January 1st, 2025. Since then, PRPO shares have increased by 8.8% and is now trading at $6.03. View the best growth stocks for 2025 here. How were Precipio's earnings last quarter? Precipio, Inc. (NASDAQ:PRPO) issued its quarterly earnings results on Thursday, March, 27th. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.74 by $0.97. The biotechnology company earned $5.45 million during the quarter, compared to the consensus estimate of $8.01 million. Precipio had a negative net margin of 17.23% and a negative trailing twelve-month return on equity of 34.01%. Read the conference call transcript. When did Precipio's stock split? Precipio's stock reverse split on Friday, September 22nd 2023. The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of Precipio? Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Precipio own? Based on aggregate information from My MarketBeat watchlists, some other companies that Precipio investors own include NVIDIA (NVDA), Meta Platforms (META), CymaBay Therapeutics (CBAY), Advanced Micro Devices (AMD), Broadcom (AVGO), CrowdStrike (CRWD) and GE Aerospace (GE). Company Calendar Last Earnings3/27/2025Today4/26/2025Next Earnings (Estimated)5/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:PRPO CIK1043961 Webwww.precipiodx.com Phone(203) 787-7888Fax402-452-5401Employees60Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,850,000.00 Net Margins-17.23% Pretax Margin-17.23% Return on Equity-34.01% Return on Assets-25.27% Debt Debt-to-Equity Ratio0.02 Current Ratio0.73 Quick Ratio0.60 Sales & Book Value Annual Sales$18.53 million Price / Sales0.49 Cash FlowN/A Price / Cash FlowN/A Book Value$10.16 per share Price / Book0.59Miscellaneous Outstanding Shares1,504,000Free Float1,285,000Market Cap$9.07 million OptionableNo Data Beta1.04 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (NASDAQ:PRPO) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.